A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Subjects
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine
- Indications Ebola virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors Janssen Vaccines and Prevention
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 29 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.